Ambeed.cn

首页 / / / 热休克蛋白 / Ganetespib

Ganetespib {[allProObj[0].p_purity_real_show]}

货号:A156855 同义名: STA-9090

Ganetespib (STA-9090) 是一种 HSP90 抑制剂,在各种血液和实体瘤细胞系中表现出强效细胞毒性。它还通过抑制 HIF-1α 和 STAT3 在结直肠癌中表现出抗血管生成作用。

Ganetespib 化学结构 CAS号:888216-25-9
Ganetespib 化学结构
CAS号:888216-25-9
Ganetespib 3D分子结构
CAS号:888216-25-9
Ganetespib 化学结构 CAS号:888216-25-9
Ganetespib 3D分子结构 CAS号:888216-25-9
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Ganetespib 纯度/质量文件 产品仅供科研

货号:A156855 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]
JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]
BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]
J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]
PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]
更多 >

Ganetespib 生物活性

描述 HSP90 (heat shock protein 90) is a cellular ubiquitous molecular chaperone responsible for promoting the conformational mutation and stabilization of several client oncoproteins, including Met, B-Raf, p53, Akt, and Kit, function of which is required by tumor cells to maintain appropriate client protein expression necessary for proliferation and survival. Ganetespib is a novel HSP90 inhibitor which is a resorcinol-containing triazole compound unrelated to the first class of HSP90 inhibitors, geldanamycin, 17-AAG and 17-DMAG. As both AKT and KIT are the client protein of HSP90 and are stabilized by it, inhibition of HSP90 by 100nM Ganetespib for 24h caused downregulation of both KIT and AKT only on protein level in BR can C2 cells, as well as a disruption of the association of HSP90 with Kit. Meanwhile, as upregulation of HSP70 is a consequence of HSP90 inhibition, exposure to Ganetespib also caused an induction of HSP70 expression in cells. STA-9090 led to 72-hour growth inhibition of malignant canine mast cell lines C2 and BR with IC50 values of 19nM and 4nM, respectively, much lower than 17-AAG (IC50=948nm (C2) and 44 nm (BR)). Treatment with Ganetespib caused cell apoptosis, shown as increased Annexin V-phycoerythrin [PE] /7-amino-actinomycin D (7-AAD) and increased Sub-G1 level in C2, BR, and BMCMC treated with 100nM Ganetespib for 24 or 48h, cleaved PARP induced by 100 or 1000nM Ganetespib for 24h in BR and C2 cells, and increased caspase3/7 in C2 cells treated with 50 or 75nM Ganetespib for 24h. Intravenous injection with Ganetespib at concentration of 25mg/kg, 3 days on and 2 days off, for 17 days significantly inhibited tumor growth in the C2 xenograft model[1].
作用机制 Ganetespib can bind in the ATP-binding domain at the N-terminus of HSP90. [1]

Ganetespib 细胞研究

细胞系 浓度 检测类型 检测时间 活动说明 数据源
35612 Growth Inhibition Assay IC50=38 nM 24784839
5637 Growth Inhibition Assay IC50=44 nM 24784839
639-V Growth Inhibition Assay IC50=10 nM 24784839
647-V Growth Inhibition Assay IC50=27 nM 24784839

Ganetespib 动物研究

Dose Mice (i.v.): min = 25 mg/kg[2], max = 100 mg/kg[3] (i.v.)
Administration i.v.
Pharmacokinetics
Animal Rats[4]
Dose 20 mg/kg
Administration i.v.
T1/2 6.4 h
Tmax 0.083 h
Cmax 110 μM
AUC 36.1 μM·h

Ganetespib 参考文献

[1]Lin TY, Bear M, et al. The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors. Exp Hematol. 2008;36(10):1266-77.

[2]Shimamura T, Perera SA, et al. Ganetespib (STA-9090), a nongeldanamycin HSP90 inhibitor, has potent antitumor activity in in vitro and in vivo models of non-small cell lung cancer. Clin Cancer Res. 2012 Sep 15;18(18):4973-85.

[3]Nagaraju GP, Mezina A, et al. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib. Eur J Cancer. 2016 Jan;52:109-19.

[4]Zhou D, Liu Y, et al. A rat retinal damage model predicts for potential clinical visual disturbances induced by Hsp90 inhibitors. Toxicol Appl Pharmacol. 2013 Dec 1;273(2):401-9.

Ganetespib 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.74mL

0.55mL

0.27mL

13.72mL

2.74mL

1.37mL

27.44mL

5.49mL

2.74mL

Ganetespib 技术信息

CAS号888216-25-9
分子式C20H20N4O3
分子量 364.398
别名 STA-9090
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Keep in dark place,Inert atmosphere,2-8°C

溶解度

DMSO: 105 mg/mL(288.15 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方

IP 2% DMSO+2% Tween80+40% PEG300+water 4.4 mg/mL clear

PO 0.5% CMC-Na 30 mg/mL suspension

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。